201 related articles for article (PubMed ID: 12499205)
1. A type II pathway for fatty acid biosynthesis presents drug targets in Plasmodium falciparum.
Waller RF; Ralph SA; Reed MB; Su V; Douglas JD; Minnikin DE; Cowman AF; Besra GS; McFadden GI
Antimicrob Agents Chemother; 2003 Jan; 47(1):297-301. PubMed ID: 12499205
[TBL] [Abstract][Full Text] [Related]
2. Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum.
Waller RF; Keeling PJ; Donald RG; Striepen B; Handman E; Lang-Unnasch N; Cowman AF; Besra GS; Roos DS; McFadden GI
Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12352-7. PubMed ID: 9770490
[TBL] [Abstract][Full Text] [Related]
3. Validation of Putative Apicoplast-Targeting Drugs Using a Chemical Supplementation Assay in Cultured Human Malaria Parasites.
Uddin T; McFadden GI; Goodman CD
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109165
[TBL] [Abstract][Full Text] [Related]
4. Understanding the biology of the Plasmodium falciparum apicoplast; an excellent target for antimalarial drug development.
Chakraborty A
Life Sci; 2016 Aug; 158():104-10. PubMed ID: 27381078
[TBL] [Abstract][Full Text] [Related]
5. The plastid of Plasmodium spp.: a target for inhibitors.
Sato S; Wilson RJ
Curr Top Microbiol Immunol; 2005; 295():251-73. PubMed ID: 16265894
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the Plasmodium falciparum and P. berghei glycerol 3-phosphate acyltransferase involved in FASII fatty acid utilization in the malaria parasite apicoplast.
Shears MJ; MacRae JI; Mollard V; Goodman CD; Sturm A; Orchard LM; Llinás M; McConville MJ; Botté CY; McFadden GI
Cell Microbiol; 2017 Jan; 19(1):. PubMed ID: 27324409
[TBL] [Abstract][Full Text] [Related]
7. Antimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum.
Qidwai T; Khan F
Chem Biol Drug Des; 2012 Aug; 80(2):155-72. PubMed ID: 22487082
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum.
Ramya TN; Mishra S; Karmodiya K; Surolia N; Surolia A
Antimicrob Agents Chemother; 2007 Jan; 51(1):307-16. PubMed ID: 17060533
[TBL] [Abstract][Full Text] [Related]
9. Triclosan inhibit the growth of the late liver-stage of Plasmodium.
Singh AP; Surolia N; Surolia A
IUBMB Life; 2009 Sep; 61(9):923-8. PubMed ID: 19701949
[TBL] [Abstract][Full Text] [Related]
10. Paradigm shifts in malaria parasite biochemistry and anti-malarial chemotherapy.
Surolia N; RamachandraRao SP; Surolia A
Bioessays; 2002 Feb; 24(2):192-6. PubMed ID: 11835284
[TBL] [Abstract][Full Text] [Related]
11. Type II fatty acid synthesis is essential only for malaria parasite late liver stage development.
Vaughan AM; O'Neill MT; Tarun AS; Camargo N; Phuong TM; Aly AS; Cowman AF; Kappe SH
Cell Microbiol; 2009 Mar; 11(3):506-20. PubMed ID: 19068099
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid metabolism in the Plasmodium apicoplast: Drugs, doubts and knockouts.
Shears MJ; Botté CY; McFadden GI
Mol Biochem Parasitol; 2015; 199(1-2):34-50. PubMed ID: 25841762
[TBL] [Abstract][Full Text] [Related]
13. The initiating steps of a type II fatty acid synthase in Plasmodium falciparum are catalyzed by pfACP, pfMCAT, and pfKASIII.
Prigge ST; He X; Gerena L; Waters NC; Reynolds KA
Biochemistry; 2003 Feb; 42(4):1160-9. PubMed ID: 12549938
[TBL] [Abstract][Full Text] [Related]
14. Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum.
Surolia N; Surolia A
Nat Med; 2001 Feb; 7(2):167-73. PubMed ID: 11175846
[TBL] [Abstract][Full Text] [Related]
15. The apicoplast: a plastid in Plasmodium falciparum and other Apicomplexan parasites.
Foth BJ; McFadden GI
Int Rev Cytol; 2003; 224():57-110. PubMed ID: 12722949
[TBL] [Abstract][Full Text] [Related]
16. Recombinant expression and biochemical characterization of the unique elongating beta-ketoacyl-acyl carrier protein synthase involved in fatty acid biosynthesis of Plasmodium falciparum using natural and artificial substrates.
Lack G; Homberger-Zizzari E; Folkers G; Scapozza L; Perozzo R
J Biol Chem; 2006 Apr; 281(14):9538-46. PubMed ID: 16467310
[TBL] [Abstract][Full Text] [Related]
17. Apicoplast Metabolism: Parasite's Achilles' Heel.
Kadian K; Gupta Y; Singh HV; Kempaiah P; Rawat M
Curr Top Med Chem; 2018; 18(22):1987-1997. PubMed ID: 30499407
[TBL] [Abstract][Full Text] [Related]
18. Analogues of thiolactomycin as potential anti-malarial and anti-trypanosomal agents.
Jones SM; Urch JE; Brun R; Harwood JL; Berry C; Gilbert IH
Bioorg Med Chem; 2004 Feb; 12(4):683-92. PubMed ID: 14759729
[TBL] [Abstract][Full Text] [Related]
19. Apicoplast acetyl Co-A carboxylase of the human malaria parasite is not targeted by cyclohexanedione herbicides.
Goodman CD; Mollard V; Louie T; Holloway GA; Watson KG; McFadden GI
Int J Parasitol; 2014 Apr; 44(5):285-9. PubMed ID: 24583112
[TBL] [Abstract][Full Text] [Related]
20. Antimalarial drug targets and drugs targeting dolichol metabolic pathway of Plasmodium falciparum.
Qidwai T; Priya A; Khan NA; Tripathi H; Khan F; Darokar MP; Pal A; Bawankule DU; Shukla RK; Bhakuni RS
Curr Drug Targets; 2014 Apr; 15(4):374-409. PubMed ID: 23848395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
